Edited by Peter Hillerberg1 min readStories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Banks and healthcare giants report earnings this week. Options traders are taking sides early.
Norfolk Southern shows a 0% positive options bet ratio over the past seven days. Every tracked order leans bearish. The stock carries an RSI of just 40 and a short score of 40.8. A Q3 earnings call is imminent. Traders appear to be positioning for a disappointment.
Brookfield Asset Management sits in the same camp. Its positive options bet percentage is zero over the past week. The stock is down 15% year-to-date and trades with an RSI near 35.
On the other side, call flow dominates in several large industrial names. Parker-Hannifin, CSX, and Monster Beverage each show a 100% positive bet share over the past seven days. Monster stands out most. The stock has fallen 44% year-to-date. A 100% call-skew reading on a name that beaten-down points to a contrarian positioning shift, not routine optimism.
UnitedHealth Group is one to watch heading into its Q3 earnings call. Its options score is not extreme, but an analyst return potential of 28% alongside a mid-40s RSI suggests the market is pricing in more risk than most healthcare names.
AbbVie draws added attention from ORTEX alt data. Drug trial completion date slippage is running 2.1 standard deviations below its own history, a sign of faster-than-expected trial completions. That context is worth noting alongside any options positioning in pharma names this week.
The broadest signal across the market is sector divergence. Calls dominate in infrastructure, energy pipelines, and consumer names. Puts dominate in transports and financials. With bank earnings starting Friday, that split is unlikely to hold for long.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
